Macrophage-Specific SCAP Promotes Liver and Adipose Tissue Damage in a Lean NAFLD Model: Lean, Mean, Proinflammatory Machine

Overview

Journal Cell Mol Gastroenterol Hepatol

Specialty Gastroenterology

Date 2022 May 2

PMID 35500675

Authors

Lindsey Kennedy

Heather Francis

Gianfranco Alpini

Affiliations

Soon will be listed here.

References

Li D, Liu M, Li Z, Zheng G, Chen A, Zhao L . Sterol-resistant SCAP Overexpression in Vascular Smooth Muscle Cells Accelerates Atherosclerosis by Increasing Local Vascular Inflammation through Activation of the NLRP3 Inflammasome in Mice. Aging Dis. 2021; 12(3):747-763. PMC: 8139202. DOI: 10.14336/AD.2020.1120. View

Kuchay M, Martinez-Montoro J, Choudhary N, Fernandez-Garcia J, Ramos-Molina B . Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. Biomedicines. 2021; 9(10). PMC: 8533092. DOI: 10.3390/biomedicines9101346. View

Luo X, Li H, Ma L, Zhou J, Guo X, Woo S . Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. Gastroenterology. 2018; 155(6):1971-1984.e4. PMC: 6279491. DOI: 10.1053/j.gastro.2018.09.010. View

Zhao J, Hu L, Gui W, Xiao L, Wang W, Xia J . Hepatocyte TGF-β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let-7b-5p. Hepatol Commun. 2022; 6(6):1301-1321. PMC: 9134819. DOI: 10.1002/hep4.1892. View

Shan Z, Ju C . Hepatic Macrophages in Liver Injury. Front Immunol. 2020; 11:322. PMC: 7180226. DOI: 10.3389/fimmu.2020.00322. View

Feng R, Du S, Wang C, Li Y, Liu L, Guo F . Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol. 2014; 20(47):17932-40. PMC: 4273143. DOI: 10.3748/wjg.v20.i47.17932. View

Ye Q, Zou B, Yeo Y, Li J, Huang D, Wu Y . Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020; 5(8):739-752. DOI: 10.1016/S2468-1253(20)30077-7. View

Pindjakova J, Sartini C, Lo Re O, Rappa F, Coupe B, Lelouvier B . Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation. Front Microbiol. 2017; 8:1157. PMC: 5479914. DOI: 10.3389/fmicb.2017.01157. View

Ouyang N, Gan H, He Q, Lei H, Wang S, Liu Q . Dysfunction of cholesterol sensor SCAP promotes inflammation activation in THP-1 macrophages. Exp Cell Res. 2018; 367(2):162-169. DOI: 10.1016/j.yexcr.2018.03.032. View

10.

Feldman A, Eder S, Felder T, Kedenko L, Paulweber B, Stadlmayr A . Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver. Am J Gastroenterol. 2016; 112(1):102-110. DOI: 10.1038/ajg.2016.318. View

11.

Huang X, Yao Y, Hou X, Wei L, Rao Y, Su Y . Macrophage SCAP Contributes to Metaflammation and Lean NAFLD by Activating STING-NF-κB Signaling Pathway. Cell Mol Gastroenterol Hepatol. 2022; 14(1):1-26. PMC: 9117819. DOI: 10.1016/j.jcmgh.2022.03.006. View

12.

Guo C, Chi Z, Jiang D, Xu T, Yu W, Wang Z . Cholesterol Homeostatic Regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages. Immunity. 2018; 49(5):842-856.e7. DOI: 10.1016/j.immuni.2018.08.021. View